Your support will fund the continued research and development of a vaccine to prevent cancer returning in men that have undergone radical prostatectomies, the surgical removal of the prostate.

Around 5,000 radical prostatectomies are performed each year in the UK, but between 20% and 50% of men who have their prostates removed will have their cancer return, resulting in them undergoing further radiotherapy and/or hormone therapy.

This treatment is costly, time-consuming and can have unpleasant side effects, and is not always completely successful.

The research will focus on using the new cancer-killing virus, known as HSV5-15, developed by our team at theUniversity of Surrey. mRNA vaccines have already proven to be revolutionary in preventing COVID, and this technology is promising similarly effective results in treating cancer.

It is hoped that the vaccine will save more than 1,500 men’s lives each year, and that the savings to the NHS in ongoing treatment will be considerable.

To support this and other projects that we run, please give a donation to our charity.